Publication | Closed Access

The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines

Molecular PharmacologyPsychoactive DrugDistinct Anxiolytic-like EffectsPsychiatryAddictionMedicineBehavioral PharmacologyBehavioural PharmacologyPsychopharmacologyAdverse EffectsNeuropharmacologyExperimental PharmacologyPharmacotherapyPharmacodynamic ModelingPharmacologyDrug Discovery